跳至主要内容
临床试验/NCT01354275
NCT01354275终止不适用

IVF/ICSI Outcomes of OCP Plus GnRH Agonist Protocol Versus OCP Plus GnRH Antagonist Fixed Protocol in Women With PCOS

Bulent Haydardedeoglu2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
300
试验地点
2
主要终点
Ongoing pregnancy rates

研究概览

简要总结

Outcomes of IVF/ICSI cycles of women with PCOS undergoing Gonadotropin Releasing Hormone (GnRH) agonist and GnRH Antagonist fixed protocol.

详细描述

Women with PCOS undergoing IVF/ICSI cycles will be evaluated by two different protocols. One arm of the study includes oral contraceptive plus GnRH agonist protocol with 150 IU FSH (standard dose) and second arm includes oral contraceptive plus GnRH Antagonist with 150 IU FSH dose and fixed 6th day starting of GnRH Antagonist.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
Single (Investigator)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • PCOS women undergoing ICSI cycles
  • All women will be administered 150 IU rec FSH

排除标准

  • Women having other endocrinopathies
  • women older than 35
  • third IVF/ICSI cycles
  • previous and current use of metformin

结局指标

主要结局

Ongoing pregnancy rates

时间窗: March 2009 to June 2011

Ongoing pregnancy rates measured in OCP plus GnRH Agonist and OCP plus GnRH Antagonist cycles in women with PCOS

clinical pregnancy rate

时间窗: from march 2009 to july 2011

To evaluate the clinical pregnancy rates of both study arms

Total gonadotropin use

时间窗: From march 2009 to June 2011

Total gonadotropin use of both study arms

次要结局

  • OHSS rates(from march 2009 to july 2011)
  • Total ongoing pregnancy rate(from march 2009 to june 2011)

研究者

发起方
Bulent Haydardedeoglu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Bulent Haydardedeoglu

IVF/ICSI Outcomes of OCP Plus GnRH Agonist Protocol Versus OCP Plus GnRH Antagonist Fixed Protocol in Women With PCOS: A Randomized Controlled Trial

Baskent University

研究点 (2)

Loading locations...

相似试验